- Which treatment modality should we choose for advanced hepatocellular carcinoma?
-
Kim DY
- KMID: 1117690
- Korean J Hepatol.
- 2010 Dec;16(4):353-354.
- doi: 10.3350/kjhep.2010.16.4.353
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Percutaneous Ethanol Injection Therapy in Korean with Hepatocellular Carcinoma
-
Kang HW, Kim YJ, Kim KM, Kang JM, Kim SH, Kim JH, Yoon WJ, Yoon JH, Yoon YB, Lee HS
- KMID: 1066041
- Korean J Gastroenterol.
- 2003 Dec;42(6):502-509.
BACKGROUND/AIMS: Percutaneous ethanol injection therapy (PEIT) is widely used for the treatment of hepatocellular carcinoma (HCC). However, its long-term therapeutic efficacy is not verified in Korea, one of hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
-
Ji SK, Cho YK, Ahn YS, Kim MY, Park YO, Kim JK, Kim WT
- KMID: 1118875
- Korean J Radiol.
- 2008 Dec;9(6):534-540.
- doi: 10.3348/kjr.2008.9.6.534
OBJECTIVE: While the prognostic factors of survival for patients with hepatocellular carcinoma (HCC) who underwent transarterial chemoembolization (TACE) are well known, the clinical significance of performing selective TACE for HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Polyvinyl Alcohol Embolization Adjuvant to Oily Chemoembolization in Advanced Hepatocellular Carcinoma with Arterioportal Shunts
-
Kim YJ, Lee HG, Park JM, Lim YS, Chung MH, Sung MS, Yoo WJ, Lim HW
- KMID: 1110728
- Korean J Radiol.
- 2007 Aug;8(4):311-319.
- doi: 10.3348/kjr.2007.8.4.311
OBJECTIVE: To assess the feasibility and safety of polyvinyl alcohol (PVA) embolization adjuvant to transarterial oily chemoembolization (P-TACE) in advanced hepatocellular carcinoma (HCC) with arterioportal shunts (APS). MATERIALS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparison of Patients With Hepatocellular Carcinoma Between A Short-term (Less Than 6 months) Survival Group and A Long-term (Over 24 Months) Survival Group After Treatment with Transcatheter Arterial Chemoembolization
-
Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH
- KMID: 1123169
- Korean J Hepatol.
- 2002 Jun;8(2):189-200.
BACKGROUND/AIM: Although hepatocellular carcinoma(HCC) shows poor prognosis, transcatheter hepatic arterial chemoembolization(TACE) can improve survival rate in some patient groups. This study investigated the synergy effect of the different clinical indices... -
- CITED
-
- Close
- SHARE
-
- Close
